Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol (NCT06413433)
A Phase 3, Randomized, Double-blind, Placebo-Controlled Trial of Solriamfetol in Adults With Binge Eating Disorder (BED)
🩺 Plain-English Summary (8th-Grade Level)
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol for the treatment of binge eating disorder (BED) in adults.
Who can join: Review the eligibility criteria below.
Location: Clinical Research Site — Encino, California
Age range: 18 Years to 55 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (45 Sites)
Showing the first 25 of 45 sites.
- Clinical Research Site — Encino, California
- Clinical Research Site — Garden Grove, California
- Clinical Research Site — Long Beach, California
- Clinical Research Site — Mission Viejo, California
- Clinical Research Site — San Diego, California
- Clinical Research Site — Santa Ana, California
- Clinical Research Site — Walnut Creek, California
- Clinical Research Site — West Covina, California
- Clinical Research Site — Colorado Springs, Colorado
- Clinical Research Site — Cromwell, Connecticut
- Clinical Research Site — Clermont, Florida
- Clinical Research Site — Fort Myers, Florida
- Clinical Research Site — Jacksonville, Florida
- Clinical Research Site — Lauderhill, Florida
- Clinical Research Site — Miami, Florida
- Clinical Research Site — Miami, Florida
- Clinical Research Site — Miami Lakes, Florida
- Clinical Research Site — Miami Lakes, Florida
- Clinical Research Site — Orlando, Florida
- Clinical Research Site — Orlando, Florida
- Clinical Research Site — Marietta, Georgia
- Clinical Research Site — Overland Park, Kansas
- Clinical Research Site — Boston, Massachusetts
- Clinical Research Site — Methuen, Massachusetts
- Clinical Research Site — Saint Charles, Missouri
📞 Contact the Study Coordinator
Phone: (212) 332-5061
Email: sol-bed-301@axsome.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Binge-Eating Disorder
- Low Intensity Focused Ultrasound for Binge Eating Disorder — Morgantown, West Virginia
- A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder — Boston, Massachusetts
- Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder — New York, New York
- Compuls-BED-Severity — Québec,
- Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans — West Haven, Connecticut
Explore by condition: All Binge-Eating Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.